Next Article in Journal
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)
Previous Article in Journal
Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation
Previous Article in Special Issue
Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(5), 554; https://doi.org/10.3390/ph17050554
Action Date Notes Link
article pdf uploaded. 25 April 2024 16:35 CEST Version of Record https://www.mdpi.com/1424-8247/17/5/554/pdf-vor
article supplementary file uploaded. 25 April 2024 16:35 CEST - https://www.mdpi.com/1424-8247/17/5/554#supplementary
article xml file uploaded 29 April 2024 11:08 CEST Original file -
article xml uploaded. 29 April 2024 11:09 CEST Update https://www.mdpi.com/1424-8247/17/5/554/xml
article pdf uploaded. 29 April 2024 11:09 CEST Updated version of record https://www.mdpi.com/1424-8247/17/5/554/pdf
article html file updated 29 April 2024 11:11 CEST Original file https://www.mdpi.com/1424-8247/17/5/554/html
Back to TopTop